The global veterinary endotracheal tubes market size is expected to reach USD 17.66 million by 2030, registering a CAGR of 8.50% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by an increasing pet population undergoing surgical procedures, coupled with healthcare expenditure, pet insurance, and a growing number of veterinary facilities. For instance, in 2022 according to the global animal health association, there will be around 1 billion or more pets worldwide and pet ownership will increase rapidly all around the world.
The COVID-19 pandemic impacted the market notably. This included disruption in the supply chain, reduced access to veterinary services, impact on trade and exports, and economic constraints on farmers. The manufacturing of veterinary products also was hampered due to a lack of proper materials for both equipment and disposables. However, during COVID-19, there was a high number of pet adoption rate, and hence post COVID-19, most of the pet owner visited hospitals to get their pets treated and tested, which included the usage of endotracheal tubes for carrying out some major surgeries that required general anesthesia.
Rising healthcare expenditure towards pets drives the adoption of veterinary endotracheal tubes, as most of the pet owners are concerned about their pets and do not mind spending high amounts to get their pets treated. During emergencies, pet owners rely on hospitals to get their pets treated, and in such situations, endotracheal tubes are used to keep the pet stable during surgeries or emergency situations thereby elevating the use of veterinary endotracheal tubes.
Based on animal, the dog segment dominated the market in 2024 with a revenue share of 40.82%. The cats segment is projected to grow at the fastest CAGR of about 9.01% over the forecast period
Based on product type, the cuffed type segment attributed to the largest share in 2024. The uncuffed segment on the other hand is anticipated to grow with a significant CAGR during the forecast period.
In 2024, in terms of end-use, the hospitals segment held the largest revenue share. The clinics segment is anticipated to grow to grow at the fastest CAGR of over 8% during the forecast period
In 2024, North America held the largest regional share of more than 31.90% of the market. Asia Pacific is anticipated to grow at the fastest CAGR of about 9.81% owing to the thriving veterinary hospital sector in key markets
Please note The report will be delivered in 2-3 business days upon order notification.